These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12882925)
21. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852 [TBL] [Abstract][Full Text] [Related]
23. Mutation of the circadian clock gene Per2 alters vascular endothelial function. Viswambharan H; Carvas JM; Antic V; Marecic A; Jud C; Zaugg CE; Ming XF; Montani JP; Albrecht U; Yang Z Circulation; 2007 Apr; 115(16):2188-95. PubMed ID: 17404161 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age. van der Kaay D; Deal C; de Kort S; Willemsen R; Leunissen R; Ester W; Paquette J; van Doorn J; Hokken-Koelega A J Clin Endocrinol Metab; 2009 Apr; 94(4):1386-92. PubMed ID: 19158202 [TBL] [Abstract][Full Text] [Related]
25. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. Vicent D; Ilany J; Kondo T; Naruse K; Fisher SJ; Kisanuki YY; Bursell S; Yanagisawa M; King GL; Kahn CR J Clin Invest; 2003 May; 111(9):1373-80. PubMed ID: 12727929 [TBL] [Abstract][Full Text] [Related]
32. Effect of endothelium-specific insulin resistance on endothelial function in vivo. Duncan ER; Crossey PA; Walker S; Anilkumar N; Poston L; Douglas G; Ezzat VA; Wheatcroft SB; Shah AM; Kearney MT Diabetes; 2008 Dec; 57(12):3307-14. PubMed ID: 18835939 [TBL] [Abstract][Full Text] [Related]
33. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. Bang P; Brismar K; Rosenfeld RG; Hall K J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573 [TBL] [Abstract][Full Text] [Related]
34. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645 [TBL] [Abstract][Full Text] [Related]
35. Regulation of insulin-like growth factor binding protein-1 during the 24-hour metabolic clock and in response to hypoinsulinemia induced by fasting and Sandostatin in normal women. Holden JP; Butzow TL; Laughlin GA; Ho M; Morales AJ; Yen SC J Soc Gynecol Investig; 1995; 2(1):38-44. PubMed ID: 9420847 [TBL] [Abstract][Full Text] [Related]
36. RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium. Messmer-Blust AF; Philbrick MJ; Guo S; Wu J; He P; Guo S; Li J Circ Res; 2012 Sep; 111(8):991-1001. PubMed ID: 22843786 [TBL] [Abstract][Full Text] [Related]
37. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914 [TBL] [Abstract][Full Text] [Related]
38. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Duncan ER; Walker SJ; Ezzat VA; Wheatcroft SB; Li JM; Shah AM; Kearney MT Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1311-9. PubMed ID: 17711985 [TBL] [Abstract][Full Text] [Related]
39. Glucose intolerance in aging male IGFBP-3 transgenic mice: differential effects of human IGFBP-3 and its mutant IGFBP-3 devoid of IGF binding ability. Nguyen KH; Yao XH; Erickson AG; Mishra S; Nyomba BL Endocrinology; 2015 Feb; 156(2):462-74. PubMed ID: 25490144 [TBL] [Abstract][Full Text] [Related]
40. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Wheatcroft SB; Kearney MT; Shah AM; Ezzat VA; Miell JR; Modo M; Williams SC; Cawthorn WP; Medina-Gomez G; Vidal-Puig A; Sethi JK; Crossey PA Diabetes; 2007 Feb; 56(2):285-94. PubMed ID: 17259371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]